The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BRAF V600E-mutated anaplastic thyroid carcinoma (ATC) and treatment with BRAF-inhibitors: Real-world data from a single-institution, still far from the cure.
 
Francesca Platini
No Relationships to Disclose
 
Elisa Ortolan
No Relationships to Disclose
 
Stefano Cavalieri
No Relationships to Disclose
 
Giacomo Massa
No Relationships to Disclose
 
Daria Maria Filippini
No Relationships to Disclose
 
Salvatore Alfieri
No Relationships to Disclose
 
Cristiana Bergamini
No Relationships to Disclose
 
Carlo Resteghini
No Relationships to Disclose
 
Ester Orlandi
No Relationships to Disclose
 
Biagio Paolini
No Relationships to Disclose
 
Cesare Piazza
No Relationships to Disclose
 
Federica Perrone
No Relationships to Disclose
 
Elena Tamborini
No Relationships to Disclose
 
Linda Ferrarini
No Relationships to Disclose
 
Mara Serena Serafini
No Relationships to Disclose
 
Vera Cappelletti
No Relationships to Disclose
 
Maria Grazia Daidone
No Relationships to Disclose
 
Lisa F. Licitra
Consulting or Advisory Role - Amgen and Nanobiotics Sa; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Debiopharm Group; Doxapharma; Eisai; GlaxoSmithKline; Incyte; Merck Serono; MSD; Nanobiotix; Novartis; Roche; SOBI
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Eisai (Inst); Exelixis (Inst); IRX Therapeutics (Inst); Medpace (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Merck Serono; MSD
 
Laura Deborah Locati
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; McCann Health; Merck Serono; MSD
Speakers' Bureau - Eisai
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; Ipsen; Merck Serono; MSD